GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (WBO:ABT) » Definitions » Debt-to-Asset

Abbott Laboratories (WBO:ABT) Debt-to-Asset : 0.21 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Abbott Laboratories Debt-to-Asset?

Abbott Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €990 Mil. Abbott Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €13,341 Mil. Abbott Laboratories's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was €67,137 Mil. Abbott Laboratories's debt to asset for the quarter that ended in Dec. 2023 was 0.21.


Abbott Laboratories Debt-to-Asset Historical Data

The historical data trend for Abbott Laboratories's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Debt-to-Asset Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.27 0.25 0.24 0.21

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.23 0.22 0.21 -

Competitive Comparison of Abbott Laboratories's Debt-to-Asset

For the Medical Devices subindustry, Abbott Laboratories's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Debt-to-Asset falls into.



Abbott Laboratories Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Abbott Laboratories's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(990.36 + 13340.516) / 67137.238
=0.21

Abbott Laboratories's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(990.36 + 13340.516) / 67137.238
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories  (WBO:ABT) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Abbott Laboratories Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (WBO:ABT) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (WBO:ABT) Headlines

From GuruFocus

Q2 2023 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2023 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024